Tim Guilliams, Ph.D., Healx Ltd.

Tim Guilliams, Ph.D. Tim is a social entrepreneur passionate about delivering the next generation of therapeutics to rare disease patients in need. He is the Founder and Chief Executive of Healx and the Co‐Founder and Chair of the Cambridge Rare Disease Network (CRDN), a charity aiming to foster dialogue and awareness around rare diseases in Cambridge, UK.

Prior to Healx and CRDN, Tim worked on University‐Industry interactions in the area of Life Sciences for the UK Government Department for Business, Innovation and Skills (BIS). He obtained his PhD in the field of Biophysical Neuroscience at the University of Cambridge. He is also a Junior Associate Fellow of the Centre for Science and Policy (CSaP). Before moving to Cambridge, he obtained an MEng in Bio‐Engineering from the University of Brussels (VUB).

Sessions

11:50 AM - 12:05 PM

Developing a Large-Scale and Hypothesis-Free Drug Discovery Model for Rare Diseases

Every rare disease deserves a treatment. To address this challenge, Healx developed a scalable and hypothesis-free drug discovery model. Integrating patient group expertise and multi-omic data with an AI-based platform enables novel ways of identifying treatment opportunities for rare diseases. This session will discuss a large-scale, parallel and hypothesis-free rare disease drug discovery approach.

Download Latest Agenda